Endovia Health Sciences Issues 510,951 Shares to C/M Capital

What Happened
Endovia Health Sciences, Inc. announced in an 8-K that on August 25, 2026 it sold and issued 510,951 shares of its common stock to C/M Capital Master Fund, LP under a Securities Purchase Agreement dated September 19, 2025 (the "ELOC Agreement"). The transaction generated total gross proceeds of $107,610.62. The ELOC Agreement was previously disclosed in the company’s Form 8‑K filed September 25, 2025.

Key Details

• Buyer: C/M Capital Master Fund, LP (purchaser under the ELOC Agreement).
• Shares issued: 510,951 common shares on August 25, 2026.
• Proceeds: $107,610.62 in gross proceeds from the issuance.
• Compliance: Sales were made pursuant to exemptions under Section 4(a)(2) and Rule 506(b); purchaser’s resales are registered on Endovia’s Form S-1 (File No. 333-298112), effective August 24, 2026.

Why It Matters
This filing documents a small equity issuance that increases the company’s outstanding shares and brought in roughly $108k in cash. The resale registration on the company’s Form S-1 means the purchaser is able to resell the shares under that registration, which can affect share liquidity and potential supply in the market. For investors, the item is mainly informational about capital raising and share issuance terms rather than a change to management or operating results.